Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410122 · ClinicalTrials.gov registry record
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 15
- Enrollment target
NCT02410122: Completed study, sponsored by Johns Hopkins University.
NCT02410122 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02410122 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
While a fair amount of clinical data on Stargardt disease type 1 (STGD1) have been published, very little is known about Stargardt disease type 4 (STGD4). The ProgStar 04 study is an important opportunity to leverage the infrastructure, clinical trials sites, methods, and central reading center of the ProgStar program to investigate the progression of STGD4 and will help to establish patient cohorts worldwide for future clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410122
The ClinicalTrials.gov registry entry for NCT02410122 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02410122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410122 about?
NCT02410122 is a clinical study titled "The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy". While a fair amount of clinical data on Stargardt disease type 1 (STGD1) have been published, very little is known about Stargardt disease type 4 (STGD4). The ProgStar 04 study is an important opportunity to leverage the infrastructure, clinical trials sites, methods, and central reading center of t...
What is the current status of trial NCT02410122?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2014-12. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT02410122?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.